In this webinar, Prof Julian Hamilton-Sheild and Prof Timothy Barrett will present the findings of the 2015-16 BPSU study.
Free to attend
Novo Nordisk has provided a grant to the Royal College of Paediatrics and Child Health to support the creation, development and delivery of this webinar. Novo Nordisk has had no influence over the webinar's content and full editorial control remains the responsibility of the RCPCH.
Speakers:
Professor Julian Hamilton-Sheild, Professor of Diabetes and Metabolic Endocrinology/Paediatrician
Julian is Professor of Diabetes and Metabolic Endocrinology and trained at Bristol and the Hospitals for Sick Children, London. He has been an honorary consultant paediatrician at Bristol Royal Hospital for Children since 1997. His main research interests encompass neonatal glucose metabolism, childhood obesity and its treatment, diabetes mellitus and the development of insulin resistance through childhood. He is a theme lead for 'Optimising nutrition to improve the health of children with chronic disorders' within the Biomedical Research Unit and a member of the BRU executive group.
Professor Timothy Barrett, Institute of Cancer and Genomic Sciences; Leonard Parsons Professor of Paediatrics and Child Health; Director, Centre for Rare Disease Studies
Timothy Barrett is Leonard Parsons Professor of Paediatrics and Child Health in the Institute of Cancer and Genomic Sciences. He is an Honorary Consultant in Paediatric Endocrinology and Diabetes and Programme Director for the Wellcome Trust Clinical Research Facility at Birmingham Children’s Hospital. Timothy is also the Director of the Centre for Rare Disease Studies (CRDS) Birmingham.
Timothy has published over 100 research papers in scientific journals as well as reviews and book chapters in the fields of paediatrics, diabetes and genetics of childhood diabetes syndromes. He has received major grants from The Medical Research Council, The Wellcome Trust, European Union Directorate General for Health and Consumer Affairs, Diabetes UK and Wellchild.
He leads NHS national specialist commissioned services in rare diabetes syndromes, and a busy clinical practice of general diabetes, type 2 diabetes in children, and tertiary endocrinology. He is an enthusiastic teacher and communicator on the themes of genetics and monogenic diabetes, and lectures widely at national and international level. Timothy contributes to the local and national media and advises the BBC on stories relating to childhood obesity and metabolism.
Learning outcomes
- Understanding how UK children are affected by Type 2 diabetes
- Understanding of the causes and development of Type 2 diabetes.
- Develop an understanding of the current issues associated with Type 2 diabetes
Benefit to delegates
- Understanding of the causes and development of Type 2 diabetes will increase and this will improve the diagnosis and treatment for the condition in children and young people under the age of 17
- Developing an understanding of the current issues associated with Type 2 diabetes could also help target future approaches to preventing and managing the condition
Audience:
- General Paediatricians
- Paediatric trainees
- Community Paediatricians
- Paediatric Endocrionologists
- Midwives and Health Visitors
- GPs & GP trainees
- Public Health doctors
- Dieticians
It is also suitable for an international audience, with caveats on data (which is UK & Ireland) and treatment approaches which will be most relevant to the UK context